# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-024664
Filing Date
2025-05-12
Accepted
2025-05-12 16:07:29
Documents
102
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | aqst-20250331.htm iXBRL | 10-Q | 1183540
2 | EX-10.1 | mschobelsignedconsulting.htm | EX-10.1 | 13114
3 | EX-31.1 | q12025ex311.htm | EX-31.1 | 10877
4 | EX-31.2 | q12025ex312.htm | EX-31.2 | 11093
5 | EX-32.1 | q12025ex321.htm | EX-32.1 | 6374
6 | EX-32.2 | q12025ex322.htm | EX-32.2 | 6440
12 |  | mschobelsignedconsulting001.jpg | GRAPHIC | 305229
13 |  | mschobelsignedconsulting002.jpg | GRAPHIC | 286074
14 |  | mschobelsignedconsulting003.jpg | GRAPHIC | 107213
15 |  | mschobelsignedconsulting004.jpg | GRAPHIC | 169327
| Complete submission text file | 0001628280-25-024664.txt |  | 9029113

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | aqst-20250331.xsd | EX-101.SCH | 68411
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | aqst-20250331_cal.xml | EX-101.CAL | 64755
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | aqst-20250331_def.xml | EX-101.DEF | 386614
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | aqst-20250331_lab.xml | EX-101.LAB | 747487
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | aqst-20250331_pre.xml | EX-101.PRE | 587188
104 | EXTRACTED XBRL INSTANCE DOCUMENT | aqst-20250331_htm.xml | XML | 947196

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38599 | Film No.: 25934805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)